, Cancer, prostate-National Comprehensive Cancer Network guidelines for treatment of Cancer by site, 2018.

N. D. James, M. R. Spears, and N. W. Clarke, Survival with newly diagnosed metastatic prostate cancer in the "docetaxel era": data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019), Eur Urol, vol.67, pp.1028-1038, 2015.

F. E. Von-eyben and K. Kairemo, Acquisition with 11 C-choline and 18 F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and metaanalysis, Ann Nucl Med, vol.30, pp.385-392, 2016.

N. Mottet, J. Bellmunt, and M. Bolla, EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent, Eur Urol, vol.71, pp.618-629, 2017.

G. Shen, H. Deng, S. Hu, and Z. Jia, Comparison of choline-PET/ CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis, Skelet Radiol, vol.43, pp.1503-1513, 2014.

B. E. Hillner, B. A. Siegel, and L. Hanna, Impact of 18 F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry, J Nucl Med, vol.55, pp.574-581, 2014.

I. Jambor, A. Kuisma, and S. Ramadan, Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18 F-NaF PET/CT and whole body 1.5 T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial, Acta Oncol, vol.55, pp.59-67, 2016.

U. Tateishi, S. Morita, and M. Taguri, A meta-analysis of (18)F-fluoride positron emission tomography for assessment of metastatic bone tumor, Ann Nucl Med, vol.24, pp.523-531, 2010.

F. Mosavi, S. Johansson, and D. T. Sandberg, Whole-body diffusion-weighted MRI compared with 18 F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma, Am J Roentgenol, vol.199, pp.1114-1120, 2012.

F. Barchetti, A. Stagnitti, and V. Megna, Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment, Eur Rev Med Pharmacol Sci, vol.20, pp.3770-3776, 2016.

M. Beheshti, R. Vali, and P. Waldenberger, Detection of bone metastases in patients with prostate cancer by 18 F fluorocholine and 18 F fluoride PET-CT: a comparative study, Eur J Nucl Med Mol Imaging, vol.35, pp.1766-1774, 2008.

W. Langsteger, S. Balogova, and V. Huchet, Fluorocholine ( 18 F) and sodium fluoride ( 18 F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading, Q J Nucl Med Mol Imaging, vol.55, pp.448-457, 2011.

, Guideline on clinical evaluation of diagnostic agents, In: Guidel. Clin. Eval. Diagn. Agents, 2009.

D. Amico, A. V. Moul, J. Carroll, and P. R. , Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy, J Urol, vol.172, pp.42-46, 2004.

Z. S. Zumsteg, D. E. Spratt, and P. B. Romesser, The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy, Eur Urol, vol.67, pp.1009-1016, 2015.

B. J. Trock, M. Han, and S. J. Freedland, Prostate cancerspecific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy, JAMA, vol.299, pp.2760-2769, 2008.

P. Cornford, J. Bellmunt, and M. Bolla, EAU-ESTROSIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer, Eur Urol, vol.71, pp.630-642, 2017.

M. Hodolic, L. Michaud, and V. Huchet, Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey, Radiol Oncol, vol.48, pp.20-28, 2014.

H. Kjölhede, G. Ahlgren, and H. Almquist, Combined 18F-fluorocholine and 18 F-fluoride positron emission tomography/ computed tomography imaging for staging of high-risk prostate cancer, BJU Int, vol.110, pp.1501-1506, 2012.

J. D. Soyka, M. A. Muster, and D. T. Schmid, Clinical impact of 18 F-choline PET/CT in patients with recurrent prostate cancer, Eur J Nucl Med Mol Imaging, vol.39, pp.936-943, 2012.

Q. Gillebert, V. Huchet, and C. Rousseau, 18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: detection rate, impact on management and adequacy of impact. A prospective multicentre study, PLoS One, vol.13, p.191487, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01802330

F. Ceci, K. Herrmann, and P. Castellucci, Impact of 11 C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial, Eur J Nucl Med Mol Imaging, vol.41, pp.2222-2231, 2014.

F. E. Lecouvet, M. Simon, and B. Tombal, Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa), Eur Radiol, vol.20, pp.2973-2982, 2010.

L. Evangelista, L. Cuppari, and F. Zattoni, The future of choline pet in the era of PMSA, Q J Nucl Med Mol Imaging, vol.18, pp.3062-3067, 2018.

A. Afshar-oromieh, C. M. Zechmann, and A. Malcher, Comparison of PET imaging with a 68 Ga-labelled PSMA ligand and 18, 2014.

F. , based PET/CT for the diagnosis of recurrent prostate cancer, Eur J Nucl Med Mol Imaging, vol.41, pp.11-20

J. J. Morigi, P. D. Stricker, and P. J. Van-leeuwen, Prospective comparison of 18 F-fluoromethylcholine versus 68 Ga-PSMA PET/ CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy, J Nucl Med, vol.56, pp.1185-1190, 2015.

M. Gauthé, O. Belissant, and A. Girard, TEP/TDM et récidive biologique d'adénocarcinome prostatique: apport du, p.68, 2017.

, Ga-PSMA-11 lorsque la 18 F-fluorocholine n'est pas contributive, Prog En Urol, vol.27, pp.474-481

M. Gauthé, O. Bélissant, and J. Zhang-yin, , 2017.

, Ga-PSMA-11 quand la 18 F-fluorocholine ne localise pas la récidive biologique du cancer de la prostate : à propos d'un cas et revue de la littérature